3.8 Article

Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis

Journal

CURRENT CLINICAL MICROBIOLOGY REPORTS
Volume 3, Issue 4, Pages 204-215

Publisher

SPRINGER
DOI: 10.1007/s40588-016-0044-4

Keywords

Varicella-zoster virus; Glycoprotein; Receptor; Fusion; Replication; Pathogenesis

Categories

Funding

  1. NIH [AI10254601, AI20459]

Ask authors/readers for more resources

Purpose of Review Varicella-zoster virus (VZV), an alphaherpesvirus that causes chicken pox (varicella) and shingles (herpes zoster), is a medically important pathogen that causes considerable morbidity and, on occasion, mortality in immunocompromised patients. Herpes zoster can afflict the elderly with a debilitating condition, postherpetic neuralgia, triggering severe, untreatable pain for months or years. The lipid envelope of VZV, similar to all herpesviruses, contains numerous glycoproteins required for replication and pathogenesis. This study aims to summarize the current knowledge about VZV glycoproteins and their roles in cell entry, replication, and pathogenesis. Recent Findings The functions for some VZV glycoproteins are known, such as gB, gH, and gL, in membrane fusion, cell-cell fusion regulation, and receptor binding properties. However, the molecular mechanisms that trigger or mediate VZV glycoproteins remain poorly understood. Summary VZV glycoproteins are central to successful replication but their modus operandi during replication and pathogenesis remains elusive requiring further mechanistic-based studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available